These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19581764)

  • 1. [Pathology of nonalcoholic steatohepatitis].
    Jeen YM; Jin SY
    Korean J Hepatol; 2009 Jun; 15(2):122-30. PubMed ID: 19581764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonalcoholic steatohepatitis: a clinicopathological analysis of liver biopsy in 32 cases].
    Meng JR; Zheng RD; Zhang MF; Guo YH; Lin MZ; Dai TJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):339-41. PubMed ID: 16546742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of liver biopsy in the diagnosis of NASH].
    Kanemasa K; Sumida Y
    Nihon Rinsho; 2006 Jun; 64(6):1119-25. PubMed ID: 16768119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steatosis and steatohepatitis in diabetic patient].
    Hůlek P; Dresslerová I
    Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Behling C; Newbury R; Deutsch R; Nievergelt C; Schork NJ; Lavine JE
    Hepatology; 2005 Sep; 42(3):641-9. PubMed ID: 16116629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
    Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
    J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.
    Younossi ZM; Stepanova M; Rafiq N; Makhlouf H; Younoszai Z; Agrawal R; Goodman Z
    Hepatology; 2011 Jun; 53(6):1874-82. PubMed ID: 21360720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of nonalcoholic fatty liver disease.
    Yeh MM; Brunt EM
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA; Feldstein AE
    J Dig Dis; 2011 Feb; 12(1):10-6. PubMed ID: 21091933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinicopathological study on nonalcoholic steatohepatitis].
    Lang ZW; Hu ZJ; Wang SK; Zhang LJ; Meng X; Song CZ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):81-3. PubMed ID: 12648399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic steatohepatitis].
    Duvnjak M; Virović L
    Acta Med Croatica; 2003; 57(3):189-99. PubMed ID: 14582465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.